Sputnik V fails to come in from the cold
The Russian-made vaccine posts competitive phase III data – but not on the easily stored formulation.
Novavax and J&J join the Covid-19 vaccine push
Relief as two further pandemic vaccines succeed, but the data confirm variants to be a problem.
Merck’s Covid-19 vaccines head for the scrapheap
Merck & Co’s move illustrates how hard it will be for the second wave of Covid-19 vaccine candidates to succeed.
2020 drug approvals rise despite Covid-19
Worries about a stricter US FDA come to nothing, as last year’s approval total beats 2019’s.
